London Stock Exchange Notice Cancellation - OKYO PHARMA LIMITED (0889A)

TIDMOKYO

RNS Number : 0889A

London Stock Exchange Notice

22 May 2023

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE

22/05/2023 - 08:00

At the request of the company the following securities have been cancelled from admission to trading on London Stock Exchange with effect from the time and date of this notice.

 
OKYO PHARMA LIMITED 
213800VVN5CB56Y15A05 
ORDINARY SHARES    (BD3FV87)(GG00BD3FV870)  OKYO PHAR/NPV VTG FPD 
 OF NO PAR VALUE, 
 FULLY PAID 
                   -----------------------  --------------------- 
 

If you have any queries relating to the above, please contact Market Operations at the London Stock Exchange on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

SENUKSVROUUVAAR

(END) Dow Jones Newswires

May 22, 2023 03:00 ET (07:00 GMT)